Skip to main content
. Author manuscript; available in PMC: 2013 Sep 3.
Published in final edited form as: Ann Allergy Asthma Immunol. 2011 Apr 22;107(1):22–28. doi: 10.1016/j.anai.2011.03.011

Table 4.

Participant Characteristics by Complete Case and Missing Values for %FEV1 at Baseline

Characteristic Baseline %FEV1 obtained (n = 352) Baseline %FEV1 not obtained (n = 184) P valuea
Age, years [IQR]b 9.4 [7.6,11.9] 8.6 [6.3,11.5] 0.006
Male gender 201 (57) 129 (57) 0.47
Respiratory rate (/min), median [IQR]b 24 [ 21,30] 26 [22,30] 0.047
Magnesium treatment 42 (12) 25 (14) 0.58
Continuous albuterol treatment 225 (64) 120 (65) 0.77
Disposition 0.061
    Discharge to home 286 (81) 141 (77)
    Admit to floor bed 50 (14) 25 (14)
    Admit to PICU 16 (5) 18 (10)
GINA controlled categoryc 186 (53) 87(47) 0.22

Data are presented n (%) or median [IQR] where IQR = interquartile range.

a

Wilcoxon rank sum test for continuous variables and Chi-square test for categorical variables

b

Interquartile range

c

Meeting controlled category of Global Initiative for Asthma chronic severity score for preceding 3-month period